Fenugreek's testosterone data is honestly mixed. Mansoori 2020 meta-analysis pooled the fenugreek trials and found a modest +5-10% free T effect with high heterogeneity — some trials showed nothing, others a small bump. Wankhede 2016 in aging men saw +6% free T at 500 mg Testofen. The T uplift is real but small — not what fenugreek is best at.
Tongkat Ali vs Fenugreek
Reviewed
Verified by SAC team
+20
XP on completion
Fenugreek is the rare 'common testosterone booster' that has actual published human evidence — but it's narrow. Its strongest data is on libido at 500-600 mg/day standardised Testofen extract (Wilborn 2010, Steels 2011, Mansoori 2020 meta). Tongkat ali is broader: 10+ RCTs, +10-37% testosterone uplift, cortisol reduction, ADAM-population data. Below: 6 rounds head-to-head, and an honest verdict that doesn't dismiss fenugreek but doesn't oversell it either.
Contender A
Fenugreek (Testofen)
Saponin · 6+ RCTs · libido +25% · ≥50% furostanolic saponins
The rare common booster with real evidence — but it's narrow. Strongest data is on libido + sexual function, not raw testosterone. The right pick for libido-specific complaints.
8.2/10
Best forLibido-specific complaint · tongkat T-moved-but-libido-didn't reader
Read the full ranking →
Contender B
Tongkat Ali (Physta/LJ100)
Quassinoid · 10+ RCTs · T +37% · eurycomanone ≥2%
Displaces SHBG, directly raises free testosterone, reduces cortisol. The broader hormonal pick — wider RCT base and the bigger lever on the T number itself.
9.2/10
Best forBroader hormonal lift · ADAM profile · T + recovery + drive
Read the full ranking →
How we scored each round
Five criteria that matter for a real-world decision between these two herbs, weighted by what actually drives the buy. Each round, both contenders get a 0-10 score based on the published trials. The winner is whoever scores higher on that round; ties are explicit when both perform comparably.
- Testosterone effect25%
Magnitude of testosterone uplift vs placebo — raw effect on total + free T.
- Libido effect25%
Magnitude + consistency of libido / sexual-function improvements across trials.
- Trial-evidence base20%
Number of placebo-controlled RCTs, sample size, meta-analysis support.
- Mechanism + safety15%
Mechanistic clarity + adverse-event profile + drug interactions.
- Cost + accessibility15%
Monthly cost at the trial dose + availability of standardised product.
6 rounds — head-to-head on the criteria that matter
- Round 1
Round 1 · Testosterone uplift magnitude
Raw effect on total + free T vs placeboFenugreek (Testofen)6.5 Tongkat Ali (Physta/LJ100)9.5 Tongkat ali's testosterone effect is the headline. Talbott 2013: +37% total T at Physta 200 mg / 4 wk in stressed adults. Tambi 2012 ADAM-population: testosterone restored to eugonadal range in 90% of low-T men. Pooled meta-analyses report standardised mean differences in the 1.0-1.4 range — large effect by Cohen's convention. The raw magnitude is hard to argue with.
- Round 2
Round 2 · Libido specificity
Libido + sexual-function improvements vs placeboFenugreek (Testofen)9.5 Fenugreek's strongest evidence sits here. Steels 2011 (8 wk, Testofen 600 mg): significant improvements in libido score, sexual arousal, and orgasm rating vs placebo. Wilborn 2010 (8 wk, resistance-trained men, Testofen 500 mg): libido + recovery improvements alongside training adaptations. Mansoori 2020 meta confirms libido as the most consistent fenugreek endpoint across studies. It's the most reliable libido signal of any common booster on the shelf.
Tongkat Ali (Physta/LJ100)8.0 Tongkat moves libido too — but as a downstream consequence of free-T elevation rather than a direct libido-pathway hit. Most tongkat trials report libido + morning-drive improvements in 2-4 weeks, but the signal varies more by population than fenugreek's does. Strong in ADAM-profile men, less consistent in already-normal-T responders.
- Round 3
Round 3 · Mechanism specificity
Clarity + elegance of mechanism of actionFenugreek (Testofen)6.5 Fenugreek's mechanism is murkier. The current best guess: furostanolic saponins modestly inhibit aromatase (preserving more T from estrogen conversion) and 5α-reductase (modulating T → DHT). Neither has been pinned down with the same confidence as tongkat's SHBG mechanism. The libido endpoint is reproducible but the WHY is still partly under investigation.
Tongkat Ali (Physta/LJ100)9.0 Tongkat's mechanism is one of the cleanest in the natural-product space. Eurycomanone competitively binds SHBG, displacing testosterone and raising the bioactive free fraction. Secondary cortisol-reduction effect has independent in-vivo support. Mechanism + outcome track together: bigger SHBG displacement, bigger T uplift.
- Round 4
Round 4 · Trial-evidence base
RCT count, sample size, meta-analysis supportFenugreek (Testofen)7.5 Fenugreek has a real evidence base — 6-8 placebo-controlled trials on Testofen specifically, plus the Mansoori 2020 meta-analysis covering testosterone endpoints. Sample sizes are moderate (n=50-120 per trial). The body of evidence is concentrated on libido endpoints with a smaller secondary set on T. Less broad than tongkat's, but more than any other non-tongkat herbal booster on the shelf.
Tongkat Ali (Physta/LJ100)9.0 Tongkat has 10+ placebo-controlled trials on standardised extracts, pooled sample size approaching 1,000, multiple meta-analyses, and population-specific RCTs (stressed adults, ADAM hypogonadism, athletes, aging men). The Tambi & Imran 2022 meta-analysis pooled 5 RCTs at SMD 1.35 — a large effect. Broader trial base across more populations.
- Round 5
Round 5 · Cost + safety
Monthly cost at trial dose + adverse-event profileFenugreek (Testofen)8.0 Testofen at 600 mg/day runs $15-25/month — comparable or slightly cheaper than tongkat. Adverse-event profile is clean across trials: mild GI in a minority, and the well-known maple-syrup body odor from sotolone in some users. No drug interactions of note for the average buyer. Avoid in pregnancy and with anticoagulants (mild platelet effect at high doses).
Tongkat Ali (Physta/LJ100)8.0 Physta or LJ100 at 200 mg/day runs $22-45/month — slightly premium pricing reflecting the smaller patent ecosystem. Safety profile clean over 6+ month trials. Identifiable interactions: don't stack with TRT (additive), don't take after 2 p.m. (sleep disruption), irritability at the top of the dose range. Same adverse-event count as fenugreek, different specific risks.
- Round 6
Round 6 · Stacking + combinability
Can these be co-administered? Does it make sense?Fenugreek (Testofen)8.5 Fenugreek's mechanism (aromatase + 5α-reductase modulation, primarily libido endpoint) doesn't conflict with tongkat's (SHBG displacement, primarily T endpoint). The two hit different endpoints. Adding fenugreek to a tongkat protocol for the reader who wants BOTH the T number and the libido number moved is a legitimate take — and one the typical 'just pick one' framing misses.
Tongkat Ali (Physta/LJ100)8.5 Tongkat plus fenugreek is the most sensible herbal-booster stack on the market. Tongkat handles the broader hormonal lift; fenugreek adds libido specificity. No documented adverse interactions, no mechanistic competition. Cost is additive ($35-65/month combined), but the outcome coverage is broader than either alone.
After 6 rounds
1
Fenugreek (Testofen)
2
Ties
3
Tongkat Ali (Physta/LJ100)
Tongkat first for everyone — except the libido-specific reader who already tried it
After 6 rounds, the scoreboard is 3-1 with 2 ties — tongkat takes the broader hormonal case. That tracks the evidence honestly: it has the bigger T uplift, the cleaner mechanism, the wider RCT base.
But the round fenugreek wins is the one that matters most for a specific reader segment. If your #1 complaint is libido — not testosterone numbers, libido — fenugreek's signal is the most consistent of any common booster. Testofen 600 mg/day for 8 weeks is the protocol. The Wilborn 2010 and Steels 2011 trials are reproducible.
The default first-cycle pick is tongkat ali. 200 mg Physta or LJ100 / day for 8-12 weeks. Re-test. If T moved on labs but libido didn't shift in real life — that's the exact moment fenugreek earns its place in the stack. Add it for cycle two. No mechanistic conflict, no adverse interaction, different endpoints.
If both apply from the start — you want both the testosterone number and the libido specifically moved — running them together at clinical doses is a legitimate take. The 'pick only one' framing isn't always right. Tongkat 200 mg + Testofen 600 mg / day for 8-12 weeks. Cost combined: $35-65/month. Coverage: broader than either alone.
The one wrong move: picking fenugreek alone expecting a big T uplift. That's not what the evidence supports. Fenugreek is the libido specialist of the booster category — narrow, real, and best deployed against the right endpoint.
Every claim above traces back to one of these
- [1]Talbott 2013
Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects
200 mg/day of Physta tongkat ali for 4 weeks raised total testosterone +37% and lowered cortisol −16% vs placebo. Cornerstone trial for the 200 mg dose recommendation.
- [2]Tambi 2012
Standardised water-soluble extract of Eurycoma longifolia, Tongkat ali, as testosterone booster for managing men with late-onset hypogonadism
Multicenter ADAM-population trial: 200 mg Physta daily restored testosterone into the eugonadal range in 90% of men with late-onset hypogonadism over the treatment window.
- [3]Wilborn 2010
Effects of a purported aromatase and 5α-reductase inhibitor on hormone profiles in college-age men
Resistance-trained men supplementing Testofen fenugreek 500 mg/day for 8 weeks alongside training showed libido + recovery improvements with modest hormone-profile shifts vs placebo. Foundational fenugreek + lifting trial.
- [4]Steels 2011
Physiological aspects of male libido enhanced by standardized Trigonella foenum-graecum extract and mineral formulation
Testofen 600 mg/day for 8 weeks significantly improved libido score, sexual arousal, and orgasm rating vs placebo in healthy adult men. The cornerstone fenugreek libido trial.
- [5]Mansoori 2020
Effect of fenugreek extract supplement on testosterone levels in male: A meta-analysis of clinical trials
Pooled meta-analysis of fenugreek RCTs on testosterone endpoints. Modest +5-10% free testosterone uplift with high heterogeneity across studies — libido endpoints more consistent than raw T endpoints.
- [6]Wankhede 2016
Beneficial effects of fenugreek glycoside supplementation in male subjects during resistance training
Fenugreek glycoside supplementation 500 mg/day for 8 weeks in resistance-trained men showed improved body-composition + strength outcomes alongside modest free-testosterone shifts. Replicates the Wilborn fenugreek + lifting framework.
▸ Build your character
Stop reading. Start leveling.
One free quiz · personalized AI Coach path · 4 missions this week. Build your character, build your life.
- AI Coach picks 4 missions tailored to your goal
- Earn XP, build streaks, level up four chapters
- All evidence-based — no fluff, no upsells